Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018–2019

• Published in: Vaccine 2020-02, Vol.38 (8), p.1925-1932
• Main Authors: Castilla, Jesús, Portillo, María Eugenia, Casado, Itziar, Pozo, Francisco, Navascués, Ana, Adelantado, Marta, Gómez Ibáñez, Carlos, Ezpeleta, Carmen, Martínez-Baz, Iván
• Format: Article
• Language: English
• Subjects: Case-Control Studies; Case-control study; Confidence intervals; Health services; Humans; Immunization; Influenza; Influenza A; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza vaccine; Influenza Vaccines - administration & dosage; Influenza, Human - epidemiology; Influenza, Human - prevention & control; Influenza-like illness; Mutation; Repeated vaccination; Seasons; Sentinel Surveillance; Spain - epidemiology; Treatment Outcome; Vaccination; Vaccine effectiveness; Vaccine efficacy; Vaccines; Viruses
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2020.01.028

•The current and prior influenza vaccination effectiveness was evaluated in 2018/19.•Vaccine effectiveness was moderate against A/H1N1 and low against A/H3N2 influenza.•Vaccination in prior seasons maintained a notable protective effect.•Strains included in recent prior vaccines were as effective as the current vaccine strain.•Current and prior vaccines added their effects against influenza A/H1N1. The population targeted for influenza vaccination can be repeatedly vaccinated over successive seasons, and vaccines received in previous seasons may retain preventive effect. This study aims to estimate the effectiveness of inactivated influenza vaccines received in the current and prior seasons in the 2018–2019 season. Influenza-like illness patients attended by sentinel general practitioners or admitted to hospitals in Navarre, Spain, were tested for influenza. Vaccination status in the current and three prior seasons was obtained from the vaccination registry. The test-negative design was used to estimate the vaccine effectiveness. A total of 381 influenza A(H1N1)pdm09 cases, 341 A(H3N2) cases and 1222 controls were analysed. As compared to individuals unvaccinated in the current and three prior seasons, the influenza vaccine effectiveness against A(H1N1)pdm09 was 57% (95% confidence interval [CI]: 40%, 70%) for current season vaccination regardless of prior doses and 48% (95%CI: 14%, 68%) for vaccination in prior seasons but not in the current season. These estimates were 12% (95%CI: −23%, 37%) and 27% (95%CI: −22%, 56%), respectively, against influenza A(H3N2). Individuals vaccinated with the two A(H1N1)pdm09 strains in influenza vaccines since 2009, A/Michigan/45/2015 and A/California/07/2009, had higher protection (68%; 95%CI: 53%, 77%) than those vaccinated with A/Michigan/45/2015 only (29%, p = 0.020) or with A/California/07/2009 only (34%, p = 0.005). These results suggest moderate effectiveness of influenza vaccination against A(H1N1)pdm09 and low effectiveness against A(H3N2) influenza in the 2018–2019 season. Vaccination in prior seasons maintained a notable protective effect. Strains included in previous vaccines were as effective as the current vaccine strain, and both added their effects against influenza A(H1N1)pdm09.